HC Wainwright set a $12.00 price objective on Strata Skin Sciences, Inc. (NASDAQ:SSKN) in a report published on Wednesday, October 18th. The firm currently has a buy rating on the medical device company’s stock.
Other research analysts have also issued research reports about the stock. ValuEngine upgraded shares of Strata Skin Sciences from a strong sell rating to a sell rating in a research report on Friday, September 1st. Zacks Investment Research lowered shares of Strata Skin Sciences from a hold rating to a sell rating in a research report on Wednesday, August 16th.
Shares of Strata Skin Sciences (SSKN) opened at 1.38 on Wednesday. Strata Skin Sciences has a 12-month low of $0.43 and a 12-month high of $5.40. The company has a 50 day moving average price of $1.72 and a 200-day moving average price of $2.21. The firm’s market cap is $3.42 million.
Strata Skin Sciences (NASDAQ:SSKN) last announced its earnings results on Thursday, August 10th. The medical device company reported ($0.52) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.71) by $0.19. Strata Skin Sciences had a negative return on equity of 41.58% and a negative net margin of 18.00%. The firm had revenue of $8.70 million for the quarter, compared to analysts’ expectations of $7.98 million. Analysts expect that Strata Skin Sciences will post ($3.14) EPS for the current year.
TRADEMARK VIOLATION WARNING: “Strata Skin Sciences, Inc. (NASDAQ:SSKN) Given a $12.00 Price Target by HC Wainwright Analysts” was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this article on another website, it was stolen and republished in violation of US & international copyright and trademark laws. The original version of this article can be read at https://www.dispatchtribunal.com/2017/10/27/hc-wainwright-analysts-give-strata-skin-sciences-inc-sskn-a-12-00-price-target.html.
Strata Skin Sciences Company Profile
STRATA Skin Sciences, Inc, formerly MELA Sciences, Inc, is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging.
Receive News & Ratings for Strata Skin Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.